114 related articles for article (PubMed ID: 35480060)
1. Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load.
Zhao H; Tu H; Yu X; Su J; Zhang X; Xu K; Shi Y; Qiu Y; Sheng J
Infect Drug Resist; 2022; 15():1971-1979. PubMed ID: 35480060
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).
Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L
Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
[TBL] [Abstract][Full Text] [Related]
4. Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis.
Li X; Yuan X; Xu Z; Shi L; Huang L; Lu X; Fu J
Infect Dis Immun; 2023 Jan; 3(1):20-28. PubMed ID: 36789030
[TBL] [Abstract][Full Text] [Related]
5. Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA.
Zhou Y; Ding F; Bao W; Xue Y; Han L; Zhang X; Zhang P; Ji Y; Yin D; Bao A; Luo S; Xu Z; Liu J; Zhang M
Ann Transl Med; 2021 Apr; 9(8):665. PubMed ID: 33987363
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.
Hu X; Xing Y; Jia J; Ni W; Liang J; Zhao D; Song X; Gao R; Jiang F
Sci Total Environ; 2020 Aug; 728():138812. PubMed ID: 32335406
[TBL] [Abstract][Full Text] [Related]
7. Duration of SARS-CoV-2 RNA Shedding Is Significantly Influenced by Disease Severity, Bilateral Pulmonary Infiltrates, Antibiotic Treatment, and Diabetic Status: Consideration for Isolation Period.
Arfijanto MV; Asmarawati TP; Bramantono B; Rusli M; Rachman BE; Mahdi BA; Nasronudin N; Hadi U
Pathophysiology; 2023 May; 30(2):186-198. PubMed ID: 37218914
[TBL] [Abstract][Full Text] [Related]
8. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19.
Bennasrallah C; Zemni I; Dhouib W; Sriha H; Mezhoud N; Bouslama S; Taboubi W; Beji MO; Kacem M; Abroug H; Fredj MB; Loussaief C; Belguith AS
Int J Infect Dis; 2021 Apr; 105():463-469. PubMed ID: 33647508
[TBL] [Abstract][Full Text] [Related]
10. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.
Zheng S; Fan J; Yu F; Feng B; Lou B; Zou Q; Xie G; Lin S; Wang R; Yang X; Chen W; Wang Q; Zhang D; Liu Y; Gong R; Ma Z; Lu S; Xiao Y; Gu Y; Zhang J; Yao H; Xu K; Lu X; Wei G; Zhou J; Fang Q; Cai H; Qiu Y; Sheng J; Chen Y; Liang T
BMJ; 2020 Apr; 369():m1443. PubMed ID: 32317267
[TBL] [Abstract][Full Text] [Related]
11. Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
Kim EJ; Choi SH; Park JS; Kwon YS; Lee J; Kim Y; Lee SY; Choi EY
Yonsei Med J; 2020 Sep; 61(9):826-830. PubMed ID: 32882767
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.
Masiá M; Telenti G; Fernández M; García JA; Agulló V; Padilla S; García-Abellán J; Guillén L; Mascarell P; Asenjo JC; Gutiérrez F
Open Forum Infect Dis; 2021 Feb; 8(2):ofab005. PubMed ID: 33614814
[TBL] [Abstract][Full Text] [Related]
13. Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19.
Chen X; Zhu B; Hong W; Zeng J; He X; Chen J; Zheng H; Qiu S; Deng Y; Chan JCN; Wang J; Zhang Y
Int J Infect Dis; 2020 Sep; 98():252-260. PubMed ID: 32619760
[TBL] [Abstract][Full Text] [Related]
14. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.
Antar AAR; Yu T; Pisanic N; Azamfirei R; Tornheim JA; Brown DM; Kruczynski K; Hardick JP; Sewell T; Jang M; Church T; Walch SN; Reuland C; Bachu VS; Littlefield K; Park HS; Ursin RL; Ganesan A; Kusemiju O; Barnaba B; Charles C; Prizzi M; Johnstone JR; Payton C; Dai W; Fuchs J; Massaccesi G; Armstrong DT; Townsend JL; Keller SC; Demko ZO; Hu C; Wang MC; Sauer LM; Mostafa HH; Keruly JC; Mehta SH; Klein SL; Cox AL; Pekosz A; Heaney CD; Thomas DL; Blair PW; Manabe YC
Open Forum Infect Dis; 2021 Jun; 8(6):ofab195. PubMed ID: 34095338
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients.
Munker D; Osterman A; Stubbe H; Muenchhoff M; Veit T; Weinberger T; Barnikel M; Mumm JN; Milger K; Khatamzas E; Klauss S; Scherer C; Hellmuth JC; Giessen-Jung C; Zoller M; Herold T; Stecher S; de Toni EN; Schulz C; Kneidinger N; Keppler OT; Behr J; Mayerle J; Munker S
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33602859
[TBL] [Abstract][Full Text] [Related]
16. Detection and viral RNA shedding of SARS-CoV-2 in respiratory specimens relative to symptom onset among COVID-19 patients in Bavaria, Germany.
Woudenberg T; Eberle U; Marosevic D; Liebl B; Ackermann N; Katz K; Sing A;
Epidemiol Infect; 2021 Jun; 149():e150. PubMed ID: 34158139
[TBL] [Abstract][Full Text] [Related]
17. Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients.
Ding JG; Li J; Hong L; Yu XQ; Ye EL; Sun GQ; Zhang XX; Chen L; Sun QF
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5788-5796. PubMed ID: 32495917
[TBL] [Abstract][Full Text] [Related]
18. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
[TBL] [Abstract][Full Text] [Related]
19. Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients.
Aljunaid MA; Albeshry AM; Alshahrani NZ; Barabie SS
J Family Med Prim Care; 2022 May; 11(5):1890-1897. PubMed ID: 35800556
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
Shi D; Wu W; Wang Q; Xu K; Xie J; Wu J; Lv L; Sheng J; Guo J; Wang K; Fang D; Li Y; Li L
J Infect Dis; 2020 Aug; 222(6):910-918. PubMed ID: 32614392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
